Inuvo, Inc. INUV
Advertising · data as of November 13, 2026
Inuvo, Inc. (INUV) is a consumer discretionary company listed in the US with a market value of about $5M. In the twelve months to September 30, 2026 it had revenue of $37M and net income of -$8M, a net margin of -21.1%.
Its overall Stock Analiz score is 0.8 out of 5 (weak). The strongest part is future growth (1/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of 14% a year, a 5-year average ROIC of -40%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 99% below the current price.
About Inuvo
Inuvo is listed in the US and classified in advertising. Revenue went from $50M in 2014 to $86M in 2025, growth of about 5.2% a year. It was profitable in 0 of the last 10 years in our data. Its share count rose by 21% over three years (dilution for shareholders).
Score: 0.8 / 5
Checks passed
- Profit margin improving
- 5-year revenue growth above 8% a year
- Liabilities below 60% of assets
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $37M | $86M | $84M | $74M | $76M | $60M | $45M | $62M | $73M | $80M | $72M |
| Net income | -$8M | -$5M | -$6M | -$10M | -$13M | -$8M | -$7M | -$4M | -$6M | -$3M | -$772584 |
| Free cash flow | -$4M | -$3M | -$2M | -$4M | -$7M | -$7M | -$7M | -$7M | -$4M | -$3M | -$63352 |
| EPS (diluted) | $-0.31 | $-0.35 | $-0.40 | $-0.80 | $-1.10 | $-0.60 | $-0.90 | $-1.10 | $-1.90 | $-1.10 | $-0.30 |
| Net margin | -21.1% | -5.9% | -6.9% | -14.1% | -17.3% | -12.7% | -16.4% | -7.3% | -8.0% | -3.8% | -1.1% |
| ROIC | — | -49.2% | -30.1% | -58.1% | -45.3% | -18.6% | -31.1% | -38.7% | -37.0% | -15.0% | -7.2% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 3 analysts is $3.50, 1162% above the current price; targets range from $2.50 to $4.00; the consensus rating is “none”; expected EPS is $-0.50 for the fiscal year ending December 31, 2026.
Frequently asked questions
Is Inuvo stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 99% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Inuvo pay a dividend?
Not currently.
Is Inuvo a good stock to buy?
We do not give buy or sell advice. Inuvo scores 0.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.